Delivery Order SPE2DB22D1106-SPE2DB24FEVM6
Award Date
6/5/24
Potential Completion Date
6/6/24
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,415,606 units of the pharmaceutical product Endocet 10-325 mg tablet. The $2,183.86 order has a completion date of January 24, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a range of pharmaceuticals and medical supplies to DLA Troop Support Medical facilities, with no set-aside designation used...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,125.24 firm fixed-price delivery order is for ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product, with a performance period through March 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office Division of the major pharmaceutical distribution company Amerisourcebergen Corporation, provides for the delivery of ENDOCET 10-325 MG TABLET 100S to the Department of Defense (DoD). The contract has a ceiling value of $2,719.20 and a completion date of June 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to...
The U.S. Department of Defense's Medical Supply Chain agency awarded a $50,334.70 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Percocet tablets (10/325 mg) with an ultimate completion date of April 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,586.03 firm fixed-price delivery order is for the supply of ENDOCET 10-325 MG TABLET 100S, a medication used for pain management. The contract has an ultimate completion date of May 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,031.36 firm fixed-price delivery order is for the supply of ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,881.99 firm fixed-price delivery order contract covers the procurement of 4560837481 ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,417.05 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ENDOCET 10-325 MG TABLET 100S, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA...
This federal contract award SPE2DB22D1106|SPE2DB24FEVH1, valued at $1,469.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENDOCET 10-325 MG TABLET 100S. The contract has an ultimate completion date of June 5, 2024 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENDOCET 10-325 MG TABLET 100S. The contract has a potential value of $4,350.72 and a completion date of February 5, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this order, which falls under an existing indefinite delivery contract (IDC) with DLA valued up to...